Testosterone injections to improve quality of life for men in best supportive care.
Official title: Testosterone Supplementation in Patients in Best Supportive Care: Impact on Quality of Life
Run by Jules Bordet Institute · NCT07143279 · Data updated 2026-11-12
This pilot will test whether giving Sustanon 250 testosterone injections every 15 days can improve quality of life for men with low testosterone who are receiving best supportive (palliative) care.
Quick facts
| Phase | Early Phase 1 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years and up |
| Sex | Men only |
| Enrollment | 20 (estimated) |
| Sponsor | Jules Bordet Institute Academic / other |
| Locations | 1 site (Brussels) |
| Status | Recruiting |
| Started | February 11, 2026 |
| Main results expected | November 2026 |
| Study ends | November 2027 |
| Registry record updated | February 13, 2026 |
| Trial ID | NCT07143279 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adult men (≥18 years) in best supportive care with documented low total testosterone (<231 ng/dL), who are able to consent and who have no further anti-cancer treatment planned and decline resuscitation.
✕Probably not a fit
Patients with untreated prostate cancer, known hypersensitivity to the drug or its excipients (including peanut or soya allergy), or those with extremely limited life expectancy who cannot complete treatment may not receive benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a single-center, single-arm early-phase pilot enrolling adult men with documented hypogonadism (total testosterone < 231 ng/dL) who are receiving best supportive care and have no further therapeutic options. Participants will receive an intramuscular injection of Sustanon 250 (1 mL) on day 0 and then every 15 days, with quality of life measures tracked over the treatment period. Key exclusions include untreated prostate cancer and known hypersensitivity to the product or its excipients, including peanut or soya allergy. The study aims to collect preliminary safety and quality-of-life data to inform larger future trials.
Why it matters
Potential benefit: If successful, regular testosterone supplementation could reduce symptoms of low testosterone and improve overall well-being and quality of life for men in palliative supportive care.
How similar studies have gone: Testosterone replacement has improved symptoms in hypogonadal men in other clinical settings, but its specific use and benefits in patients receiving best supportive/palliative care are less well studied.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Male hypogonadal with total testosterone \< 231 ng/dl in best supportive care with no further therapeutic options and who do not wish to be reanimated. 2. Age ≥ 18 years old 3. Patient able to understand the patient information sheet and able to sign the Informed Consent form (ICF) prior to any study related procedure. Exclusion Criteria: 1. Untreated prostate cancer, given the risk of epiduritis. 2. Known hypersensitivity reactions to the study drug or to any excipients. 3. Known allergies to peanuts or soya.
Where it's running
-
Institut Jules Bordet
Brussels, Belgium Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Prehospital end-of-life care: how professionals use a comfort care booklet in Strasbourg
This study tests how emergency crew members in Strasbourg use a comfort care booklet when caring for patients at end of life, and what they think about it.
-
Concise coaching to guide decisions for advanced cancer patients considering palliative procedures
A coaching program delivered by lay providers will test whether it helps adults with advanced cancer make better, patient-aligned decisions about palliative surgeries or similar interventions.
-
Primary Palliative Care: A Feasibility Project for Family Health Units
This feasibility trial tests a GP training program plus a structured 12-week palliative-care visit plan to see if it can be carried out in primary care for adults with advanced illness.
-
Relaxation and breathing techniques to help with breathlessness and tiredness in cancer patients in palliative care
This study tests whether progressive muscle relaxation or deep breathing exercises can reduce dyspnea and fatigue and improve self-care in adults with cancer receiving palliative care.
-
Relief of dyspnea with high-flow nasal therapy in palliative care
This study tests whether high-flow nasal therapy helps relieve breathlessness in adults receiving palliative care.
-
Palliative and supportive care to help people with inflammatory arthritis live well
This project will see how palliative and supportive care could help adults with inflammatory arthritis live better throughout their illness.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.